Is AnaptysBio Stock a Buy? [The Motley Fool]
AnaptysBio, Inc. (ANAB)
Last anaptysbio, inc. earnings: 3/2 08:45 am
Check Earnings Report
US:NASDAQ Investor Relations:
ir.anaptysbio.com/investor-relations
Company Research
Source: The Motley Fool
AnaptysBio(NASDAQ:ANABImage source: Getty Images.AnaptysBio had $8. million in cash and equivalents on its books at the end of 09, providing ample resources for its research and development activities. The company expects a net cash burn of $60 million in 00 and claims its current funds can carry operations into 0. Cash-rich companies are better positioned to weather R&D setbacks or macro challenges like COVID-9, compared with companies in need of near-term funding.In 0, AnaptysBio forged a broad oncology partnership with Tesaro, an oncology company acquired byGlaxoSmithKlineNYSE:GSKBristol Myers SquibbNYSE:BMYThe partnerships will help advance more compounds in parallel than AnaptysBio could do alone, but they are not huge moneymakers -- not because they were bad deals, but because they were reached in the very early stages of drug development. For example, Bristol Myers Squibb will pay AnaptysBio up to $8 million for achieving certain R&D milestones, $ million in regulatory mileston
Show less
Read more
Impact Snapshot
Event Time:
ANAB
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
ANAB alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
ANAB alerts
High impacting AnaptysBio, Inc. news events
Weekly update
A roundup of the hottest topics
ANAB
News
- SA Quant ranks Goldman's small-cap stocks with largest short interest [Seeking Alpha]Seeking Alpha
- Anaptys Announces Participation in December Investor Conferences [Yahoo! Finance]Yahoo! Finance
- Anaptys Announces Participation in December Investor ConferencesGlobeNewswire
- AnaptysBio (NASDAQ:ANAB) had its "outperform" rating reaffirmed by analysts at Wedbush. They now have a $50.00 price target on the stock.MarketBeat
- AnaptysBio (NASDAQ:ANAB) had its price target lowered by analysts at HC Wainwright from $52.00 to $51.00. They now have a "buy" rating on the stock.MarketBeat
ANAB
Earnings
- 11/4/25 - Beat
ANAB
Sec Filings
- 11/26/25 - Form 8-K
- 11/21/25 - Form 8-K
- 11/21/25 - Form 8-K
- ANAB's page on the SEC website